Home | Products | About | Our Mission | Contact Interpace Diagnostics, LLC is the molecular diagnostics subsidiary of PDI, Inc. that is focused on commercializing cutting-edge molecular diagnostic tests that provide compelling clinical value. NEW ALTERNATIVES Reshaping health care product commercialization is just one of the things we do. LEARN MORE » OUR PRODUCTS Informing the treatment decisions physicians make every day. VIEW NOW » INTERPACE DIAGNOSTICS Provides unique expertise in bringing your products to market. SEE HOW » OUR PRODUCTS We focus on high-value molecular diagnostic tests that can help inform the treatment decisions physicians make every day. You can learn more about these tests or order sample collection kits by clicking on the links below. Mutational gene marker panel that can aid in the diagnosis of thyroid cancer and improve preoperative diagnostic accuracy. HEALTH CARE PROFESSIONAL » PATIENT/CAREGIVER » Request Test Kits Specimen collection kits may be ordered by physicians or other authorized health care professionals. Kits include all that is needed for sample collection and are complimentarily provided. REQUEST NOW » ABOUT INTERPACE DIAGNOSTICS Our goal at Interpace Diagnostics is to provide commercial support and launch expertise to a broad array of diagnostics companies. Information for investors can be found at www.pdi-inc.com. HISTORY For many years, pharmaceutical companies have engaged outsourced product commercialization teams to assist them in supporting and launching their products. In 2013, PDI, Inc., a major commercialization leader with over 25 years of experience, formed Interpace Diagnostics, LLC. Specifically focused on assisting molecular diagnostics companies commercialize their products, Interpace Diagnostics offers a full suite of services that include field sales management, reimbursement support, marketing, and comprehensive financial partnerships that can meet almost any need. Leading public (NASDAQ:PDII) health care commercialization company providing insight-driven: Outsourced sales and marketing expertise for pharmaceutical and biotech companies Digital and multichannel promotional solutions Engagement with health care providers Wholly owned subsidiary of PDI, Inc. focused on molecular diagnostics: Commercializing cutting-edge molecular diagnostic tests that provide compelling clinical value OUR MISSION Our mission is to achieve high value for all health care stakeholders: molecular diagnostics (MDx) and technology companies, health care providers, and payers. By combining the long and successful history of PDI, Inc. with a depth of experience specific to the diagnostics and reimbursment environments, Interpace Diagnostics provides: Knowledge of industry best practices Expertise in health care provider promotion and product commercialization Understanding of how to bring tests with high clinical value and utility to market Our unique approach allows molecular diagnostics companies the ability to bring their products to market in a more cost-effective, faster, and efficient manner. CONTACT INFORMATION CORPORATE HEADQUARTERS Interpace Diagnostics Morris Corporate Center 1, Building A 300 Interpace Parkway Parsippany, NJ 07054 844-405-9655 You can also learn more about our novel approach and the depth of support we can offer you to commercialize your products by contacting: GREG RICHARD General Manager 844-405-9655 grichard@interpacediagnostics.com ROB RENJILIAN Executive Director Marketing 844-405-9655 rrenjilian@interpacediagnostics.com Interpace Diagnostics, the molecule logo, and Power in Performance are trademarks of Interpace Diagnostics, LLC. ©2014 Interpace Diagnostics, LLC. All rights reserved.